CARLO SEBELLO: Open Payments
NPI 1801556857 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 15 payments from 8 companies in 2025. Trend: 2023 $3,318 · 2024 $2,046 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 1 | $149 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| SCILEX PHARMACEUTICALS INC. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: RELTONE 200 MG, LEQVIO, JARDIANCE, OTEZLA, FARXIGA, MOUNJARO, Wegovy, Rybelsus.
Industry payments across NJ — which companies pay providers there.
